MALIGNANT SOLID TUMOR
Clinical trials for MALIGNANT SOLID TUMOR explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT SOLID TUMOR trials appear
Sign up with your email to follow new studies for MALIGNANT SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First human test of new cancer drug halted early
Disease control TerminatedThis early-stage trial tested a new drug called GEN1078 in people with advanced solid cancers that had stopped responding to standard treatments. The main goals were to check the drug's safety, see how the body processes it, and get a first look at whether it might help shrink tu…
Matched conditions: MALIGNANT SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Genmab • Aim: Disease control
Last updated Apr 01, 2026 21:26 UTC
-
New cancer drug trial halted after early testing phase
Disease control TerminatedThis early-stage trial tested a new cancer drug called GEN1055, both alone and combined with an existing immunotherapy drug (pembrolizumab), for people with advanced solid tumors. The study aimed to find safe doses and see if the treatment could shrink tumors. The trial was termi…
Matched conditions: MALIGNANT SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Genmab • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New cancer drug safety test halted after early phase
Disease control TerminatedThis early-stage study tested the safety of a new cancer drug called ZL-1218, both alone and combined with an existing immunotherapy. It involved 34 adults with advanced solid tumors that had stopped responding to standard treatments. The main goal was to find safe dosage levels …
Matched conditions: MALIGNANT SOLID TUMOR
Phase: PHASE1 • Sponsor: Zai Lab (Hong Kong), Ltd. • Aim: Disease control
Last updated Mar 27, 2026 12:37 UTC